Factors determining the effectiveness of oral ciclosporin in the treatment of severe childhood atopic dermatitis.
Summary of "Factors determining the effectiveness of oral ciclosporin in the treatment of severe childhood atopic dermatitis."
Abstract Ciclosporin is used to treat severe atopic dermatitis (AD) where conventional therapy is either ineffective or inappropriate. Response to treatment is variable and the factors determining responsiveness are currently unclear. The aim of this study was to determine which children with severe AD are most responsive. A cohort of 35 children with severe AD who were given oral ciclosporin were retrospectively surveyed. SCORAD index was used to assess severity prior to and after treatment. Demographic and clinical data were correlated with clinical response. Ciclosporin resulted in a sustained reduction in SCORAD index of 91 (67-100)% in children where clinical skin infection was the main trigger and in whom the infection was effectively eradicated with antibiotics. If infection persisted or recurred the reduction in SCORAD index was only 44 (41-83)%. Children in whom their AD was triggered by other factors had a poor response to ciclosporin with reduction in SCORAD index of 8 (1-39)%. Oral ciclosporin is most effective in children with infection-driven AD in whom the infection is brought under control. In cases where the infection recurs or where the main triggers are non-infectious, response to ciclosporin is poorer.
Affiliation
University of Manchester, Department of Paediatric Allergy and Immunology, Royal Manchester Children's Hospital , Manchester , United Kingdom.
Journal Details
This article was published in the following journal.
Name: The Journal of dermatological treatment
ISSN: 1471-1753
Pages:
Links
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/22397497
- DOI: http://dx.doi.org/10.3109/09546634.2012.672709
Medical and Biotech [MESH] Definitions
Contraceptives, Oral, Hormonal
Oral contraceptives which owe their effectiveness to hormonal preparations.
Contraceptives, Oral, Synthetic
Oral contraceptives which owe their effectiveness to synthetic preparations.
Evaluation Studies
Works consisting of studies determining the effectiveness or utility of processes, personnel, and equipment.
Surgery, Oral
A dental specialty concerned with the diagnosis and surgical treatment of disease, injuries, and defects of the human oral and maxillofacial region.
Sox Transcription Factors
A large family of structurally-related transcription factors that were originally discovered based upon their close sequence homology to an HMG-box domain found in SEX-DETERMINING REGION Y PROTEIN. Many SOX transcription factors play important roles in regulating CELL DIFFERENTIATION. The numerous members of this family are organized in several subgroups according to structural identities found within the proteins.
PubMed Articles
Six Cases of Antihistamine-Resistant Dermographic Urticaria Treated with Oral Ciclosporin.
Background: Dermographic urticaria (DU) is characterized by strong itch and wheals induced by mechanical scratching. H(1)-receptor antagonists may reduce symptoms of DU to some extent, but other treat...
Ciclosporin Use During Pregnancy.
Ciclosporin (cyclosporine) is an immunosuppressive drug first approved for use in organ transplantation to prevent rejection. Ciclosporin is also known to be used for the treatment of psoriasis, rheum...
Ciclosporin Population Pharmacokinetics and Bayesian Estimation in Thoracic Transplant Recipients.
BACKGROUND AND OBJECTIVES: Therapeutic drug monitoring of ciclosporin has been recognized as an essential tool in the management of allograft transplant recipients, as it could help improve their outc...
Childhood nephrotic syndrome-current and future therapies.
The introduction of corticosteroids more than 50 years ago dramatically improved the prognosis of children with nephrotic syndrome. Corticosteroids remain the standard initial treatment for children w...
Aim:To develop a population pharmacokinetic model for the immunosuppressant ciclosporin in Chinese children with aplastic anemia and to identify covariates influencing ciclosporin pharmacokinetics.Met...
Clinical Trials
Long-Term Study of Ciclosporin for Atopic Dermatitis
In patients with severe adult atopic dermatitis, the safety and efficacy of OL27-400MEPC will be assessed by repeating oral administration at a dose of 3 mg/kg/day (2-5 mg/kg/day) in 2 div...
Ciclosporin in the Management of New Erythema Nodosum Leprosum
Study 2A: Ciclosporin in the management of new Erythema Nodosum Leprosum Objective: A pilot (double blind controlled) study randomizing patientsto treatment either with Ciclosporin or Pre...
A Phase III, Multicenter, Randomized, Controlled, Double-Masked Trial of NOVA22007 (Ciclosporin 0.1%) Ophthalmic Cationic Emulsion versus Vehicle in Patients with Moderate to Severe Dry Ey...
Ciclosporin in the Management of New Type 1 Reactions in Leprosy
Study 1A: Ciclosporin in the management of new Type 1 Reactions in Leprosy Objective: A randomised double blind controlled trial comparing Ciclosporin and Prednisolone,to determine wheth...
To assess the tolerability and effectiveness of rabbit antithymocyte globulin (ATG, Thymoglobuline) with ciclosporin in the first line treatment of patients with acquired severe aplastic a...
